Treatment of primary CNS lymphoma (PCNSL) following successful treatment of systemic non-Hodgkin's lymphoma (NHL): A case series

Journal of Neuro-Oncology

Volumn 113, Issue 1, 2013, Pages 27-32

  Chamberlain, Marc C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

High dose methotrexate rituximab; Peripheral stem cell transplantation; Primary CNS lymphoma; Systemic lymphoma

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; MELPHALAN; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ANEMIA; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; DRUG MEGADOSE; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; GENETIC ANALYSIS; HUMAN; HYPERGLYCEMIA; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOPHENOTYPING; INDUCTION CHEMOTHERAPY; KIDNEY DISEASE; LARGE CELL LYMPHOMA; LIVER DISEASE; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; THROMBOPHLEBITIS; WHOLE BODY RADIATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; KAPLAN-MEIER ESTIMATE; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 84876936038     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1085-7     Document Type: Article

References (25)

1. Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment of primary CNS lymphoma: the next step. J Clin Oncol 18:3144-3150
2. Batchelor T, Loeffler JS (2006) Primary CNS lymphoma. J Clin Oncol 24:1281-1288
3. DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology group 93-100. J Clin Oncol 20:4643-4648
4. Ferreri AJ, Dell'Oro S, Foppoli M et al (2006) MATLLDE regimen followed by radiotherapy is an active regimen against primary CNS lymphoma. Neurology 66:1435-1438
5. Fisher B, Seiferheld W, Schultz C et al (2005) Secondary analysis of RTOG 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma with chemotherapy and hyperfractionated radiotherapy. J Neuro Oncol 74(2):201-205
6. Gavrilovic IT, Hormgo A, Yahalom J et al (2006) Long-term follow-up of high dose methotrexate based therapy with or without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol 24:4570-4574
7. Herrlinger U, Schabert M, Brugger W et al (2002) German Cancer Society Neuro-Oncology Working group NOA-03 multicenter trial of single agent methotrexate for primary central nervous system lymphoma. Ann Neurol 51:247-252
8. Hoang-Xuan K, Tallandier L, Chinot O et al (2003) Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group. J Clin Oncol 21:2726-2731
9. Nelson DF, Martz KL, Bonner H et al (1992) Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on the prospective trial by Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Rad Oncol Biol Phys 23:9-17
10. Neuwelt EA, Goldman DL, Dahlborg SA et al (1991) Primary CNS lymphoma treated with osmótica blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9(9):1580-1590
11. Plotkin SR, Betensky RA, Hochberg FH et al (2004) Treatment of primary central nervous system lymphoma with sequential courses of high-dose methotrexate. Clin Cancer Res 10:5643-5646
12. Poortmans PMP, Kluin-Nelemans HC, Haaxma-Reiche H et al (2003) High-dose methotrexate based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group phase II trial 20962. J Clin Oncol 21:4483-4488
13. Shah GD, Yahalom J, Correa DD et al (2007) Combined immunochemotherapy with reduced whole brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25(30):4730-4735
14. Batchelor TT, Carson K, O'Neill A et al (2003) NABTT CNS Consortium: the treatment of primary central nervous system lymphoma (PCNSL) with methotrexate and deferred radiotherapy-NABTT 96-07. J Clin Oncol 21:1044-1049
15. Chamberlain MC, Johnston SK (2010) High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary CNS lymphoma. Neuro-Oncology 12(7):736-744
16. MacDonald DR, Cascino TL, Schold SC, Cairncross JG (1990) Response criteria for phase 2 studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280
17. Nadermanee A (2009) Transplantation for non-Hodgkin's lymphoma. Expert Rev Hematol 2(4):425-442
18. Rodrigues CA, Patah PA, Novis YA, Hosing C, de Lima M (2011) The role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settings. Curr Hematol Malig Rep 6(1):47-57
19. Gisselbrecht C, Glass B, Mounier N et al (2010) Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol 28(27):4184-4190
20. Oliansky DM, Czuczman M, Fisher RI, Irwin FD, Lazarus HM, Omel J, Vose J, Wolff SN, Jones RB, McCarthy PL Jr, Hahn T (2011) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review. Biol Blood Marrow Transpl 17(1):20-47
21. Jahnke K, Hummel M, Korfel A et al (2006) Detection of subclinical systemic disease in primary VNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy chain genes. J Clin Oncol 24(29):4754-4757
22. Haarer CF, Roberts RA, Frutiger YM, Grogan TM, Rimsza LM (2006) Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and non-germinal center B-cell subtypes correlates with gene expression profile and patient survival. Arch Pathol Lab Med 130(12):1819-1824
23. Abrey LE, Moskowitz CH, Mason WP et al (2001) Intensive methotrexate and Cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma. J Clin Oncol 21:4151-4156
24. Illerhaus G, Marks R, Ihorst G et al (2006) High-dose chemotherapy with autologous stem cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma. J Clin Oncol 24:3865-3870
25. Soussain C, Suzan F, Hoang-Xuan K et al (2001) Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 19:742-749